Protagonist Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injec…

Biotechnology
US, Newark [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Protagonist Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Protagonist Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Protagonist Therapeutics, Inc..

End of PTGX's Analysis
CIK: 1377121 CUSIP: 74366E102 ISIN: US74366E1029 LEI: - UEI: -
Secondary Listings
PTGX has no secondary listings inside our databases.